Zoetis Inc.
NYSE:ZTS · New York Stock Exchange
+$1.17 today
Vol 8.56M · Avg 6.20M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-49.20%
Period High
$156.75
Period Low
$74.22
Latest
$78.71
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Elevance Health Inc.
NYSE:ELV
$84.41B
Cigna Corporation
NYSE:CI
$74.30B
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$62.13B
argenx SE
NASDAQ:ARGX
$54.35B
Cencora, Inc.
NYSE:COR
$53.04B
Becton, Dickinson and Company
NYSE:BDX
$52.28B
Takeda Pharmaceutical Company Limited
NYSE:TAK
$49.32B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.14B
Haleon plc
NYSE:HLN
$39.53B
Elanco Animal Health Incorporated
NYSE:ELAN
$12.00B
What is the latest ZTS filing?
The latest filing shown is 3 dated Jun 17, 2026.
How many recent filings does ZTS have?
Intrinsic Alpha currently shows 20 recent filings for ZTS.
Explore More
Continue the stock analysis
Jump to another research area for this company.